Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients in Russia

Long-tErm Follow-uP of Antithrombotic Management Patterns In Acute CORonary Syndrome Patients in RUSsia

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01373957

Acronym

EPICOR-RUS

Enrollment

600

Registered

2011-06-15

Start date

2011-07-31

Completion date

2014-03-31

Last updated

2014-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Keywords

Acute Coronary Syndrome, antithrombotic management, STEMI, NSTE-ACS

Brief summary

EPICOR-RUS is a multi-centre, observational, prospective, longitudinal cohort study which will include patients, in a real-life setting, who are hospitalized for acute coronary syndrome (ACS) within 24 hours of symptom onset and who have a final diagnosis of Unstable Angina (UA), ST-Elevation Myocardial Infarction (STEMI) or Non-ST-Elevation Myocardial Infarction (NSTEMI). Patients will undergo clinical assessments and receive the standard medical care as determined by the treating cardiologist. Patients will not receive experimental intervention or experimental treatment as a consequence of their participation in the EPICOR-RUS observational study.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Subject must be 18 years of age or older of either gender or race * Diagnosis of STEMI, NSTEMI or UA confirmed using the following definitions

Exclusion criteria

* UA, STEMI and NSTEMI precipitated by or as a complication of surgery, trauma, or gastrointestinal (GI) bleeding or post-Percutaneous coronary intervention (PCI). * UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons. * Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances). * Already included in the EPICOR-RUS study. * Presence of serious/severe co-morbidities in the opinion of the investigator which may limit short term (i.e. 6 month) life expectancy. * Current participation in a clinical trial.

Design outcomes

Primary

Measure	Time frame
Short- and long-term medication and treatment prescribed by physicians in real-life setting	up to 2 years

Secondary

Measure	Time frame
clinical outcome (Cardiovascular events)	up to 2 years
quality of life (EQ-5D questionnaire)	up to 2 years

Countries

Russia

Outcome results